Reneo Pharmaceuticals Inc (NASDAQ:RPHM)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - RPHM

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - RPHM

  • Market Cap$291.440m
  • SymbolNASDAQ:RPHM
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS75974E1038

Company Profile

Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.

Latest RPHM news

Currently there for this company. Visit our news hub for other news .